Inhibition of Pathologic Immunoglobulin E In Food Allergy by EBF2 and Active Compound Berberine Associated with Immunometabolism Regulation.

MLA

Maskey, Anish, et al. “Inhibition of Pathologic Immunoglobulin E In Food Allergy by EBF2 and Active Compound Berberine Associated with Immunometabolism Regulation.” Journal of Allergy & Clinical Immunology, vol. 151, no. 2, Feb. 2023, p. AB228. EBSCOhost, https://doi.org/10.1016/j.jaci.2022.12.708.

APA

Maskey, A., Yang, N., Kim, M., Srivastava, K., Wang, Z., Shi, Y., Gong, Y., Wang, J., Dunkin, D., Chung, D., Zhan, J., Miao, M., Sampson, H., & Li, X.-M. (2023). Inhibition of Pathologic Immunoglobulin E In Food Allergy by EBF2 and Active Compound Berberine Associated with Immunometabolism Regulation. Journal of Allergy & Clinical Immunology, 151(2), AB228. https://doi.org/10.1016/j.jaci.2022.12.708

Chicago

Maskey, Anish, Nan Yang, Monica Kim, Kamal Srivastava, Zixi Wang, Yanmei Shi, Yixuan Gong, et al. 2023. “Inhibition of Pathologic Immunoglobulin E In Food Allergy by EBF2 and Active Compound Berberine Associated with Immunometabolism Regulation.” Journal of Allergy & Clinical Immunology 151 (2): AB228. doi:10.1016/j.jaci.2022.12.708.